Crescent Biopharma raises $143.7M in public offering on Nasdaq Jul 16, 2026 04:01PM
Crescent Biopharma Announces Closing of Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Jul 16, 2026 04:01PM
Crescent Biopharma prices $125M public offering of shares and warrants Jul 14, 2026 09:45PM
Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants Jul 14, 2026 09:45PM
Crescent Biopharma launches public offering of shares and warrants Jul 14, 2026 04:01PM


Jul 14, 2026 04:01PM Crescent Biopharma Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
May 6, 2026 07:30AM Crescent Biopharma to Present at May Investor Conferences
Feb 23, 2026 07:30AM Crescent Biopharma to Present at March Investor Conferences
Dec 4, 2025 06:35AM Crescent Biopharma raises $185 million, partners with Kelun-Biotech
Dec 4, 2025 06:35AM Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tu
Feb 24, 2020 08:00AM Catalyst Biosciences to Present at the Cowen Healthcare Conference
Jun 21, 2018 09:27AM Pre-Open Movers 06/21: (CASI) (HRTX) (DRI) (KR) Higher; (VERI) (LMNR) (AOBC) Lower (more...)
Mar 7, 2018 08:00AM Catalyst Biosciences to Present at The Cowen and Company 38th Annual Health Care Conference